M Constans, A Sureda, M J Terol, R Arranz, M D Caballero, A Iriondo, I Jarque, E Carreras, J M Moraleda, D Carrera, A León, A López, C Albó, J Díaz-Mediavilla, P Fernández-Abellán, J C García-Ruiz, F Hernández-Navarro, R Mataix, J Petit, M J Pascual, J Rifón, J García-Conde, J M Fernández-Rañada, M V Mateos, J Sierra, E Conde
BACKGROUND: Patients with primary refractory Hodgkin's disease (PR-HD) have a dismal prognosis when treated with conventional salvage chemotherapy. We analyzed time to treatment failure (TTF), overall survival (OS) and clinical variables influencing the outcome in patients undergoing autologous stem cell transplantation (ASCT) for PR-HD and reported to the Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL/TAMO). PATIENTS AND METHODS: Sixty-two patients, 41 males and 21 females with a median age of 27 years (range 13-55) were analyzed...
May 2003: Annals of Oncology: Official Journal of the European Society for Medical Oncology